C. Evan Ballantyne
Equibles does not estimate personal net worth.
Get an email with a short summary when Gain Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get GANX alertsAbout C. Evan Ballantyne
C. Evan Ballantyne is recorded as CFO at Gain Therapeutics, Inc. (GANX) since April 10, 2023. Gain Therapeutics, Inc. reported in an 8-K filed February 22, 2024 that C. Evan Ballantyne resigned as Chief Financial Officer, effective March 1, 2024. Gain Therapeutics, Inc. reported in an 8-K filed April 12, 2023 that C. Evan Ballantyne was appointed Chief Financial Officer, effective April 12, 2023. Gain Therapeutics, Inc. reported in an 8-K filed April 12, 2023 that C. Evan Ballantyne was appointed Chief Financial Officer, effective April 10, 2023. Gain Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Gain Therapeutics, Inc. includes Gene Mack (CEO, CFO and Board Member), Gene Mack, MBA (CEO, CFO and Board Member), Matthias Alder (CEO, COO and Board Member) and 3 others.
“On February 19, 2024, Gain Therapeutics, Inc. (the "Company") received notice of the resignation of C. Evan Ballantyne as the Company's Chief Financial Officer, and all other positions held at the Company, to be effective March 1, 2024.”
“Gain Therapeutics Appoints C. Evan Ballantyneas Chief Financial Officer BETHESDA, MD, April 12, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of C. Evan Ballantyne as the Company’s Chief Financial Officer, effective immediately.”
Affiliation history
-
Current
2023-04-10–present
-
2023-04-10–2024-03-01
-
Start not stated–2024-03-01
Company network
Leadership on record at Gain Therapeutics, Inc.
- Gene Mack CEO, CFO, Board Member
- Gene Mack, MBA CEO, CFO, Board Member
- Matthias Alder CEO, COO, Board Member
- Dr. Khalid Islam Chairman
- Khalid Islam Chairman
- Gianluca Fuggetta Chief Accounting Officer